Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Consolidated Net Income (2019 - 2025)

Historic Consolidated Net Income for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' Consolidated Net Income rose 1035.3% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 4438.4%. This contributed to the annual value of $117.5 million for FY2024, which is 178.37% up from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Consolidated Net Income is $50.9 million, which was up 1035.3% from $39.8 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Consolidated Net Income high stood at $87.9 million for Q3 2022, and its period low was -$9.6 million during Q3 2021.
  • Moreover, its 5-year median value for Consolidated Net Income was $29.5 million (2023), whereas its average is $30.6 million.
  • Over the last 5 years, Harmony Biosciences Holdings' Consolidated Net Income had its largest YoY gain of 5238518.52% in 2021, and its largest YoY loss of 60392.88% in 2021.
  • Quarter analysis of 5 years shows Harmony Biosciences Holdings' Consolidated Net Income stood at $19.1 million in 2021, then skyrocketed by 154.53% to $48.5 million in 2022, then crashed by 72.81% to $13.2 million in 2023, then surged by 62.84% to $21.5 million in 2024, then skyrocketed by 136.86% to $50.9 million in 2025.
  • Its last three reported values are $50.9 million in Q3 2025, $39.8 million for Q2 2025, and $45.6 million during Q1 2025.